https://scholars.lib.ntu.edu.tw/handle/123456789/627073
標題: | Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National Study | 作者: | Chen, Ching-Tso CHIH-HUNG HSU ANN-LII CHENG YU-YUN SHAO |
關鍵字: | Barcelona Clinic Liver Cancer Stage C; Hepatocellular carcinoma; National Health Insurance; reimbursement criteria; sorafenib; transarterial chemoembolization | 公開日期: | 九月-2022 | 出版社: | INT INST ANTICANCER RESEARCH | 卷: | 42 | 期: | 9 | 起(迄)頁: | 4461 | 來源出版物: | Anticancer research | 摘要: | The reimbursement criteria of sorafenib for advanced hepatocellular carcinoma (HCC) were expanded in 2016 by Taiwan's National Health Insurance (NHI) to include patients without macrovascular invasion or extrahepatic spread. This study explored sorafenib treatment outcomes before and after this expansion. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627073 | ISSN: | 0250-7005 | DOI: | 10.21873/anticanres.15946 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。